News/virtualassistantva.com

Digital Therapeutics Company Virtual Assistant: Patient Onboarding and Prescription Digital Therapy Support

Stealth Agents·

PDT Programs Are Growing — But Onboarding Friction Is Slowing Adoption

The prescription digital therapeutics (PDT) market is entering a critical growth phase. Following FDA clearances for software-based treatments in mental health, substance use disorder, and chronic disease management, companies like Pear Therapeutics, Freespira, and Limbix have demonstrated that app-based interventions can carry clinical rigor. The global digital therapeutics market is projected to reach $23.5 billion by 2030, according to Grand View Research.

But PDT programs face a distinctive onboarding challenge. Unlike a pharmaceutical prescription that is filled at a pharmacy, a prescription digital therapy requires the patient to download an application, create an account, verify their prescription access code, and navigate a digital environment — all while managing an underlying health condition. Dropout during onboarding is significant: studies published in npj Digital Medicine indicate that up to 50% of patients who receive a PDT prescription never complete initial setup.

Administrative support at the onboarding stage can meaningfully reduce that dropout rate.

What Onboarding Looks Like Without Virtual Assistant Support

Without dedicated administrative support, PDT onboarding coordination typically falls on clinical liaisons, commercial account managers, or the prescribing provider's office staff — none of whom have the bandwidth or mandate to manage it consistently. Patients receive their prescription, attempt self-service setup, encounter a barrier, and disengage before completing activation.

The barriers are often non-clinical: a mistyped access code, an app version incompatibility, confusion about whether their insurance plan covers the therapy, or uncertainty about how to log their first session. These are solvable problems that do not require clinical expertise — they require consistent, knowledgeable follow-up.

How a Virtual Assistant Transforms the PDT Onboarding Pipeline

A digital therapeutics virtual assistant manages the onboarding pipeline from prescription to first active session. VAs confirm insurance eligibility for the specific PDT product, send patients personalized setup instructions matched to their device type, follow up on access code redemption within 24 to 48 hours of prescription, and troubleshoot account creation issues without requiring clinical staff involvement.

For payer-sponsored programs, VAs coordinate benefit verification, document prior authorization requirements, and track authorization status across the population of newly prescribed patients. They also maintain onboarding completion dashboards that give commercial and clinical operations teams real-time visibility into activation rates by prescriber, payer, and geography.

Beyond initial setup, virtual assistants conduct scheduled check-ins at days 7, 14, and 30 to reinforce engagement, document session completion rates, and flag patients who have gone dormant for re-engagement outreach by the clinical team.

Supporting the Prescriber Relationship

Prescriber engagement is the commercial lifeblood of a PDT company. Physicians who have a positive experience with the onboarding process — and who see their patients actually completing therapy — are significantly more likely to prescribe again. VAs contribute to this feedback loop by preparing weekly prescriber-level outcome summaries, coordinating lunch-and-learn scheduling with commercial teams, and managing the inbound inquiry queue from provider offices that have questions about the prescribing process.

According to the Digital Therapeutics Alliance, prescriber education and streamlined prescribing workflows are among the top three drivers of PDT adoption. Administrative support that makes prescribing feel effortless is a direct commercial investment.

Scaling Without Proportional Headcount Increases

PDT companies that expand into new payer contracts or launch in new geographies face a sudden surge in patient volume that their current staff cannot absorb. Virtual assistants provide a scalable model — onboarding support capacity can be increased in weeks rather than months, without the overhead of full-time benefits or office infrastructure.

This is particularly relevant for early-stage DTx companies managing their burn rate while proving commercial viability. A lean VA-supported onboarding model demonstrates operational efficiency to investors while delivering the patient experience that drives retention metrics.

If your DTx company is losing patients between prescription and first session, Stealth Agents provides virtual assistants trained to manage PDT onboarding workflows from day one.

Sources